1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hypersomnia Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030 1.2.2 Provigil 1.2.3 Xyrem 1.2.4 Others 1.3 Market by Application 1.3.1 Global Hypersomnia Drug Market Growth by Application: 2019 VS 2023 VS 2030 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Hypersomnia Drug Market Perspective (2019-2030) 2.2 Hypersomnia Drug Growth Trends by Region 2.2.1 Global Hypersomnia Drug Market Size by Region: 2019 VS 2023 VS 2030 2.2.2 Hypersomnia Drug Historic Market Size by Region (2019-2024) 2.2.3 Hypersomnia Drug Forecasted Market Size by Region (2025-2030) 2.3 Hypersomnia Drug Market Dynamics 2.3.1 Hypersomnia Drug Industry Trends 2.3.2 Hypersomnia Drug Market Drivers 2.3.3 Hypersomnia Drug Market Challenges 2.3.4 Hypersomnia Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hypersomnia Drug Players by Revenue 3.1.1 Global Top Hypersomnia Drug Players by Revenue (2019-2024) 3.1.2 Global Hypersomnia Drug Revenue Market Share by Players (2019-2024) 3.2 Global Hypersomnia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Hypersomnia Drug Revenue 3.4 Global Hypersomnia Drug Market Concentration Ratio 3.4.1 Global Hypersomnia Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hypersomnia Drug Revenue in 2023 3.5 Hypersomnia Drug Key Players Head office and Area Served 3.6 Key Players Hypersomnia Drug Product Solution and Service 3.7 Date of Enter into Hypersomnia Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hypersomnia Drug Breakdown Data by Type 4.1 Global Hypersomnia Drug Historic Market Size by Type (2019-2024) 4.2 Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030) 5 Hypersomnia Drug Breakdown Data by Application 5.1 Global Hypersomnia Drug Historic Market Size by Application (2019-2024) 5.2 Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030) 6 North America 6.1 North America Hypersomnia Drug Market Size (2019-2030) 6.2 North America Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030 6.3 North America Hypersomnia Drug Market Size by Country (2019-2024) 6.4 North America Hypersomnia Drug Market Size by Country (2025-2030) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Hypersomnia Drug Market Size (2019-2030) 7.2 Europe Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030 7.3 Europe Hypersomnia Drug Market Size by Country (2019-2024) 7.4 Europe Hypersomnia Drug Market Size by Country (2025-2030) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Hypersomnia Drug Market Size (2019-2030) 8.2 Asia-Pacific Hypersomnia Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030 8.3 Asia-Pacific Hypersomnia Drug Market Size by Region (2019-2024) 8.4 Asia-Pacific Hypersomnia Drug Market Size by Region (2025-2030) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Hypersomnia Drug Market Size (2019-2030) 9.2 Latin America Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030 9.3 Latin America Hypersomnia Drug Market Size by Country (2019-2024) 9.4 Latin America Hypersomnia Drug Market Size by Country (2025-2030) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hypersomnia Drug Market Size (2019-2030) 10.2 Middle East & Africa Hypersomnia Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030 10.3 Middle East & Africa Hypersomnia Drug Market Size by Country (2019-2024) 10.4 Middle East & Africa Hypersomnia Drug Market Size by Country (2025-2030) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Teva 11.1.1 Teva Company Detail 11.1.2 Teva Business Overview 11.1.3 Teva Hypersomnia Drug Introduction 11.1.4 Teva Revenue in Hypersomnia Drug Business (2019-2024) 11.1.5 Teva Recent Development 11.2 Jazz Pharmaceuticals 11.2.1 Jazz Pharmaceuticals Company Detail 11.2.2 Jazz Pharmaceuticals Business Overview 11.2.3 Jazz Pharmaceuticals Hypersomnia Drug Introduction 11.2.4 Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024) 11.2.5 Jazz Pharmaceuticals Recent Development 11.3 BIOPROJET 11.3.1 BIOPROJET Company Detail 11.3.2 BIOPROJET Business Overview 11.3.3 BIOPROJET Hypersomnia Drug Introduction 11.3.4 BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024) 11.3.5 BIOPROJET Recent Development 11.4 AVADEL PHARMACEUTICALS 11.4.1 AVADEL PHARMACEUTICALS Company Detail 11.4.2 AVADEL PHARMACEUTICALS Business Overview 11.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Introduction 11.4.4 AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024) 11.4.5 AVADEL PHARMACEUTICALS Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Detail 11.5.2 GlaxoSmithKline Business Overview 11.5.3 GlaxoSmithKline Hypersomnia Drug Introduction 11.5.4 GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024) 11.5.5 GlaxoSmithKline Recent Development 11.6 Pfizer 11.6.1 Pfizer Company Detail 11.6.2 Pfizer Business Overview 11.6.3 Pfizer Hypersomnia Drug Introduction 11.6.4 Pfizer Revenue in Hypersomnia Drug Business (2019-2024) 11.6.5 Pfizer Recent Development 11.7 Theranexus 11.7.1 Theranexus Company Detail 11.7.2 Theranexus Business Overview 11.7.3 Theranexus Hypersomnia Drug Introduction 11.7.4 Theranexus Revenue in Hypersomnia Drug Business (2019-2024) 11.7.5 Theranexus Recent Development 11.8 Fisher & Paykel Healthcare 11.8.1 Fisher & Paykel Healthcare Company Detail 11.8.2 Fisher & Paykel Healthcare Business Overview 11.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Introduction 11.8.4 Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024) 11.8.5 Fisher & Paykel Healthcare Recent Development 11.9 Drive Medical 11.9.1 Drive Medical Company Detail 11.9.2 Drive Medical Business Overview 11.9.3 Drive Medical Hypersomnia Drug Introduction 11.9.4 Drive Medical Revenue in Hypersomnia Drug Business (2019-2024) 11.9.5 Drive Medical Recent Development 11.10 Merck 11.10.1 Merck Company Detail 11.10.2 Merck Business Overview 11.10.3 Merck Hypersomnia Drug Introduction 11.10.4 Merck Revenue in Hypersomnia Drug Business (2019-2024) 11.10.5 Merck Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hypersomnia Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030 Table 2. Key Players of Provigil Table 3. Key Players of Xyrem Table 4. Key Players of Others Table 5. Global Hypersomnia Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Hypersomnia Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030 Table 7. Global Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million) Table 8. Global Hypersomnia Drug Market Share by Region (2019-2024) Table 9. Global Hypersomnia Drug Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 10. Global Hypersomnia Drug Market Share by Region (2025-2030) Table 11. Hypersomnia Drug Market Trends Table 12. Hypersomnia Drug Market Drivers Table 13. Hypersomnia Drug Market Challenges Table 14. Hypersomnia Drug Market Restraints Table 15. Global Hypersomnia Drug Revenue by Players (2019-2024) & (US$ Million) Table 16. Global Hypersomnia Drug Market Share by Players (2019-2024) Table 17. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023) Table 18. Ranking of Global Top Hypersomnia Drug Companies by Revenue (US$ Million) in 2023 Table 19. Global 5 Largest Players Market Share by Hypersomnia Drug Revenue (CR5 and HHI) & (2019-2024) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Hypersomnia Drug Product Solution and Service Table 22. Date of Enter into Hypersomnia Drug Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Hypersomnia Drug Market Size by Type (2019-2024) & (US$ Million) Table 25. Global Hypersomnia Drug Revenue Market Share by Type (2019-2024) Table 26. Global Hypersomnia Drug Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 27. Global Hypersomnia Drug Revenue Market Share by Type (2025-2030) Table 28. Global Hypersomnia Drug Market Size by Application (2019-2024) & (US$ Million) Table 29. Global Hypersomnia Drug Revenue Market Share by Application (2019-2024) Table 30. Global Hypersomnia Drug Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 31. Global Hypersomnia Drug Revenue Market Share by Application (2025-2030) Table 32. North America Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 33. North America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million) Table 34. North America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million) Table 35. Europe Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. Europe Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million) Table 37. Europe Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million) Table 38. Asia-Pacific Hypersomnia Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030 Table 39. Asia-Pacific Hypersomnia Drug Market Size by Region (2019-2024) & (US$ Million) Table 40. Asia-Pacific Hypersomnia Drug Market Size by Region (2025-2030) & (US$ Million) Table 41. Latin America Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 42. Latin America Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million) Table 43. Latin America Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million) Table 44. Middle East & Africa Hypersomnia Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030 Table 45. Middle East & Africa Hypersomnia Drug Market Size by Country (2019-2024) & (US$ Million) Table 46. Middle East & Africa Hypersomnia Drug Market Size by Country (2025-2030) & (US$ Million) Table 47. Teva Company Detail Table 48. Teva Business Overview Table 49. Teva Hypersomnia Drug Product Table 50. Teva Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 51. Teva Recent Development Table 52. Jazz Pharmaceuticals Company Detail Table 53. Jazz Pharmaceuticals Business Overview Table 54. Jazz Pharmaceuticals Hypersomnia Drug Product Table 55. Jazz Pharmaceuticals Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 56. Jazz Pharmaceuticals Recent Development Table 57. BIOPROJET Company Detail Table 58. BIOPROJET Business Overview Table 59. BIOPROJET Hypersomnia Drug Product Table 60. BIOPROJET Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 61. BIOPROJET Recent Development Table 62. AVADEL PHARMACEUTICALS Company Detail Table 63. AVADEL PHARMACEUTICALS Business Overview Table 64. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Table 65. AVADEL PHARMACEUTICALS Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 66. AVADEL PHARMACEUTICALS Recent Development Table 67. GlaxoSmithKline Company Detail Table 68. GlaxoSmithKline Business Overview Table 69. GlaxoSmithKline Hypersomnia Drug Product Table 70. GlaxoSmithKline Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 71. GlaxoSmithKline Recent Development Table 72. Pfizer Company Detail Table 73. Pfizer Business Overview Table 74. Pfizer Hypersomnia Drug Product Table 75. Pfizer Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 76. Pfizer Recent Development Table 77. Theranexus Company Detail Table 78. Theranexus Business Overview Table 79. Theranexus Hypersomnia Drug Product Table 80. Theranexus Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 81. Theranexus Recent Development Table 82. Fisher & Paykel Healthcare Company Detail Table 83. Fisher & Paykel Healthcare Business Overview Table 84. Fisher & Paykel Healthcare Hypersomnia Drug Product Table 85. Fisher & Paykel Healthcare Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 86. Fisher & Paykel Healthcare Recent Development Table 87. Drive Medical Company Detail Table 88. Drive Medical Business Overview Table 89. Drive Medical Hypersomnia Drug Product Table 90. Drive Medical Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 91. Drive Medical Recent Development Table 92. Merck Company Detail Table 93. Merck Business Overview Table 94. Merck Hypersomnia Drug Product Table 95. Merck Revenue in Hypersomnia Drug Business (2019-2024) & (US$ Million) Table 96. Merck Recent Development Table 97. Research Programs/Design for This Report Table 98. Key Data Information from Secondary Sources Table 99. Key Data Information from Primary Sources List of Figures Figure 1. Global Hypersomnia Drug Market Size Comparison by Type (2024-2030) & (US$ Million) Figure 2. Global Hypersomnia Drug Market Share by Type: 2023 VS 2030 Figure 3. Provigil Features Figure 4. Xyrem Features Figure 5. Others Features Figure 6. Global Hypersomnia Drug Market Size Comparison by Application (2024-2030) & (US$ Million) Figure 7. Global Hypersomnia Drug Market Share by Application: 2023 VS 2030 Figure 8. Hospital Pharmacies Case Studies Figure 9. Retail Pharmacies Case Studies Figure 10. Online Pharmacies Case Studies Figure 11. Hypersomnia Drug Report Years Considered Figure 12. Global Hypersomnia Drug Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 13. Global Hypersomnia Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 14. Global Hypersomnia Drug Market Share by Region: 2023 VS 2030 Figure 15. Global Hypersomnia Drug Market Share by Players in 2023 Figure 16. Global Top Hypersomnia Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hypersomnia Drug as of 2023) Figure 17. The Top 10 and 5 Players Market Share by Hypersomnia Drug Revenue in 2023 Figure 18. North America Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 19. North America Hypersomnia Drug Market Share by Country (2019-2030) Figure 20. United States Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 21. Canada Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Europe Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 23. Europe Hypersomnia Drug Market Share by Country (2019-2030) Figure 24. Germany Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 25. France Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 26. U.K. Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. Italy Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. Russia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Nordic Countries Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Asia-Pacific Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Asia-Pacific Hypersomnia Drug Market Share by Region (2019-2030) Figure 32. China Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 33. Japan Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 34. South Korea Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 35. Southeast Asia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 36. India Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 37. Australia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 38. Latin America Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 39. Latin America Hypersomnia Drug Market Share by Country (2019-2030) Figure 40. Mexico Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. Brazil Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. Middle East & Africa Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. Middle East & Africa Hypersomnia Drug Market Share by Country (2019-2030) Figure 44. Turkey Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Saudi Arabia Hypersomnia Drug Market Size YoY Growth (2019-2030) & (US$ Million) Figure 46. Teva Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 47. Jazz Pharmaceuticals Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 48. BIOPROJET Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 49. AVADEL PHARMACEUTICALS Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 50. GlaxoSmithKline Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 51. Pfizer Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 52. Theranexus Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 53. Fisher & Paykel Healthcare Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 54. Drive Medical Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 55. Merck Revenue Growth Rate in Hypersomnia Drug Business (2019-2024) Figure 56. Bottom-up and Top-down Approaches for This Report Figure 57. Data Triangulation Figure 58. Key Executives Interviewed